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Michael Parker and Dominic Kwiatkowski discuss
important ethical considerations for sustainable
genomics research in Africa.enormous opportunity for the growth of African science,
but if the lessons of the past are to be learned and extract-Why research is needed?
Diseases that affect the world’s poorest people remain woe-
fully understudied relative to those affecting rich countries.
The high burden of disease in sub-Saharan Africa provides
a compelling reason for boosting medical research on the
continent and bringing the latest technologies and analyt-
ical approaches to bear on the problem. The past decade
has seen hopeful signs that the health needs of low-income
countries are gaining increased attention among scientists
and research funders, and one example of this is the growth
of genomic research in Africa. It is an important develop-
ment which, if combined with the collection of high-quality
clinical and epidemiological data, will lead to an improved
understanding of disease mechanisms and potentially
powerful new tools for tackling the spread of drug resist-
ance and emerging infections.
Genomic research in Africa presents a number of prac-
tical and ethical challenges. Some of the issues are common
to any form of medical research conducted in low-income
settings: these have been extensively discussed in the litera-
ture and are the subject of many, sometimes conflicting,
guidelines [1]. However, the development of new forms of
research collaboration and of technologies and methods
associated with genomics are also leading to the parallel
emergence of complex new ethical issues. This means that
as well as following conventional ethical guidelines,
genomics researchers need to consider a number of specific
questions in order to achieve high ethical standards.* Correspondence: Michael.parker@ethox.ox.ac.uk
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Oxford, Oxford OX3 7LF, UK
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There is much that is new about genomics, and arguably
one of its most striking features is its dependence on
international research collaboration. The growing emphasis
on building global research partnerships is potentially an
ive research practices avoided, a key requirement is the
training of a significant cohort of African scientists and cli-
nicians with relevant expertise. This has implications for
science education in African schools and universities but
also for training at more senior levels for researchers and
those running research institutions who may not have
personal experience of genomics. There is also need for
the development of a greater understanding of genomics
among those who sit on research ethics or scientific re-
view committees for whom genomics may be a relatively
new concept, and who raise concerns because of lack of
familiarity. Examples of large-scale genomics initiatives
with a significant component of research capacity building
include MalariaGEN, which brings together research
groups in more than 30 malaria endemic countries in
Africa and Asia; and the H3Africa initiative, which is
funded jointly by the National Institutes of Health and
the Wellcome Trust to promote African leadership of
genomic research. It is encouraging that these and
other capacity-building activities are starting to have an
impact, as evidenced by the emergence of new African-led
networks with a major focus on genetic research [2].Equitable research collaborations
The building of capacity is only part of what is needed
for sustainable genomic research in Africa. Another key
requirement is that international collaborative partner-
ships in genomics should be fair and equitable and that
researchers in low-income settings are treated with re-
spect as equal partners. It can be challenging to achieve
equitable scientific partnerships when there are great
disparities in resources and capacity, and this is all the
more reason to strive for real evidence of capacity buildingThis article is distributed under the terms of the Creative Commons Attribution
ons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Parker and Kwiatkowski Genome Biology  (2016) 17:44 Page 2 of 3and the creating of the conditions for equal partnership in
the future [3, 4].
One area in which issues of fairness are of particular
importance is data sharing. The sharing of genomic data
across the international scientific community is an
essential requirement for success in understanding of
diseases affecting African populations, but it is vital for
the sustainability of such research that the ground rules
for data sharing should be equitable. The challenge is to
create a level playing field between data producers and
data users that respects the legitimate interests of African
researchers who have generated samples and data. It is
important to recognize that occasionally there may be
tensions between the potential short-term benefits of
rapid data release and the longer-term benefits of fostering
sustainable scientific research in Africa. In some cases
there may be good reasons — grounded both in the im-
portance of fairness and sustainable science — for giving
preferential data access for a limited time to groups based
in low-income settings [5]. This may also be important for
the promotion of public trust and confidence.Public trust
Of paramount importance to the sustainability of genom-
ics research in Africa is that publics, research participants,
and frontline research workers should have good grounds
for placing their trust in the people and institutions con-
ducting genomic research. A recent study on attitudes to
data-sharing in low-income settings identified a great deal
of public support for sharing of data but also identified
trust, the minimizing of harm, and fairness and reciprocity
as key requirements for such support [6]. Concerns about
the sharing and uses of research samples and data across
international boundaries are not unique to low-income
countries, but they can take on particular moral and polit-
ical resonance in such contexts because of enduring global
inequalities and worries about the potential for neocolo-
nial, extractive research practices. Such worries may be
compounded by the newness and scale of genomics and
by the notion, which researchers are naturally keen to
foster, that these are particularly valuable materials and
data. If the benefits of genomic research for Africa are
to be realised, then careful attention needs to be paid
to the achievement of well-founded and sustainable
public trust and confidence in the conduct of genomic
research and the international collaborations essential
to its success. An important role in the building of public
trust and hence of sustainable scientific collaboration, par-
ticularly in the context of persisting global health and
other inequality and fragile trust, is likely to be played by
the clear articulation of the “social contract” for genomics
research in Africa and the establishment of widely
respected models of good practice [7].High ethical standards
We have chosen to highlight issues related to capacity
building, fairness in research collaboration, and public
trust because it is crucial, in our view, that greater atten-
tion is paid to these. However, it is also important to
continue to identify and address the day-to-day practical
ethical issues that genomics research in Africa presents
on the ground in real world settings.
An important example is the achievement of valid
consent. Although the requirements for the achievement
of valid consent have been a central concern of research
ethics throughout its history, genomics presents import-
ant new problems and asks difficult questions about the
role of consent and the scope of the ethical protections
it is able to provide. Valid consent is usually understood
to be consent that is informed, voluntary, and competent.
In the context of genomics, the meeting of each of these
requirements presents important practical problems.
Perhaps the greatest difficulties are those related to in-
formation and understanding: key concepts in genomic
research can be difficult to explain as are many of the
practices essential to genomics such as data-sharing
and the use of data in future as yet undetermined re-
search by researchers, often at great distance from the
context in which the data were obtained. Such uses of
future research may have the potential to make an im-
portant contribution to the understanding of the dis-
eases affecting people living in Africa; but what model
of consent is most appropriate for this? Important work
is currently being done on the development of models
of good consenting practice suited to the recruitment
of participants from low-income settings in genomic
research [8]. In high-income countries such questions
are starting to be resolved in favor of approaches com-
bining high-quality broad consent with independent
governance of data access. Research on attitudes to
data sharing in low-income settings and consultation in
the context of initiatives such as H3Africa suggest that
such models may be also acceptable here, but only where
they are complemented by additional protections such as
material transfer agreements, data access agreements, and
independent and trusted forms of governance with robust
local involvement [6].
Conclusion
There are good prima facie reasons for supporting the
growth of genomic research in low-income settings
because of its potential to improve understanding of
the diseases affecting the world’s poorest people. Such
research is only sustainable and ethical in the context
of fair research collaborations, genuine commitment
to the building of research capacity, and effective and
trusted governance informed by awareness of the ex-
pectations of those living in the settings from which
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good research practice. The achievement of high ethical
standards, for example in regard to the achievement of
valid consent, requires further work at national and inter-
national levels on the establishment of widely shared
models of good research practice. The focus must be on
the achievement of best ethical practice in real-world set-
tings. This requires the development of innovative models
for the embedding of ethics in the day-to-day conduct of
large-scale genomic research collaborations involving part-
ners from high-income and low-income settings.
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